181 related articles for article (PubMed ID: 18195571)
1. The chemokine CCL5 regulates the in vivo cell surface expression of its receptor, CCR5.
Lin YL; Mettling C; Portalès P; Rouzier R; Clot J; Reynes J; Corbeau P
AIDS; 2008 Jan; 22(3):430-2. PubMed ID: 18195571
[TBL] [Abstract][Full Text] [Related]
2. Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes.
Jalonen TO; Pulkkinen K; Ukkonen M; Saarela M; Elovaara I
J Neurol; 2002 May; 249(5):576-83. PubMed ID: 12021948
[TBL] [Abstract][Full Text] [Related]
3. The strength of the chemotactic response to a CCR5 binding chemokine is determined by the level of cell surface CCR5 density.
Desmetz C; Lin YL; Mettling C; Portalès P; Rabesandratana H; Clot J; Corbeau P
Immunology; 2006 Dec; 119(4):551-61. PubMed ID: 17177831
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of in vitro stimulated PBMC to infection with NSI HIV-1 is associated with levels of CCR5 expression and beta-chemokine production.
Blaak H; Ran LJ; Rientsma R; Schuitemaker H
Virology; 2000 Feb; 267(2):237-46. PubMed ID: 10662619
[TBL] [Abstract][Full Text] [Related]
5. The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling.
Lin YL; Mettling C; Portalès P; Réant B; Robert-Hebmann V; Reynes J; Clot J; Corbeau P
AIDS; 2006 Jun; 20(10):1369-77. PubMed ID: 16791011
[TBL] [Abstract][Full Text] [Related]
6. Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5.
Nattermann J; Nischalke HD; Feldmann G; Ahlenstiel G; Sauerbruch T; Spengler U
J Viral Hepat; 2004 Nov; 11(6):519-26. PubMed ID: 15500552
[TBL] [Abstract][Full Text] [Related]
7. CCL5 promotes proliferation of MCF-7 cells through mTOR-dependent mRNA translation.
Murooka TT; Rahbar R; Fish EN
Biochem Biophys Res Commun; 2009 Sep; 387(2):381-6. PubMed ID: 19607806
[TBL] [Abstract][Full Text] [Related]
8. Cell surface CCR5 density determines the intensity of T cell migration towards rheumatoid arthritis synoviocytes.
Desmetz C; Lin YL; Mettling C; Portalès P; Noël D; Clot J; Jorgensen C; Corbeau P
Clin Immunol; 2007 May; 123(2):148-54. PubMed ID: 17363330
[TBL] [Abstract][Full Text] [Related]
9. Effects of neferine on CCL5 and CCR5 expression in SCG of type 2 diabetic rats.
Li G; Xu H; Zhu S; Xu W; Qin S; Liu S; Tu G; Peng H; Qiu S; Yu S; Zhu Q; Fan B; Zheng C; Li G; Liang S
Brain Res Bull; 2013 Jan; 90():79-87. PubMed ID: 23063706
[TBL] [Abstract][Full Text] [Related]
10. In vitro pharmacoregulation of CC chemokine ligand 5 and its receptor CCR5 in diffuse lung diseases.
Sekerova V; Subrtova D; Mrazek F; Gibejova A; Kolek V; du Bois RM; Petrek M
Mediators Inflamm; 2003 Aug; 12(4):215-20. PubMed ID: 14514472
[TBL] [Abstract][Full Text] [Related]
11. CCL5/CCR5 axis promotes the motility of human oral cancer cells.
Chuang JY; Yang WH; Chen HT; Huang CY; Tan TW; Lin YT; Hsu CJ; Fong YC; Tang CH
J Cell Physiol; 2009 Aug; 220(2):418-26. PubMed ID: 19334035
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor KLF2 regulates the migration of naive T cells by restricting chemokine receptor expression patterns.
Sebzda E; Zou Z; Lee JS; Wang T; Kahn ML
Nat Immunol; 2008 Mar; 9(3):292-300. PubMed ID: 18246069
[TBL] [Abstract][Full Text] [Related]
13. Relationship between expression of chemokine receptors CCR3, CCR5 and CXCR3 on CD4(+) T cells and spontaneous abortion in mice.
Jiang PJ; Lin QD; Bao SM; Zhao AM; Zhang Y; Xiao SJ
Chin Med J (Engl); 2009 Feb; 122(4):390-5. PubMed ID: 19302742
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin down regulates mRNA expression of RANTES and CCR5 in posttransplant renal recipients with hyperlipidemia.
Li Q; Wang D; Wang Y; Xu Q
Transplant Proc; 2006 Nov; 38(9):2899-904. PubMed ID: 17112859
[TBL] [Abstract][Full Text] [Related]
15. MCP-1 derived from stromal keratocyte induces corneal infiltration of CD4+ T cells in herpetic stromal keratitis.
Lee SK; Choi BK; Kang WJ; Kim YH; Park HY; Kim KH; Kwon BS
Mol Cells; 2008 Jul; 26(1):67-73. PubMed ID: 18594181
[TBL] [Abstract][Full Text] [Related]
16. Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpression.
Sabbe R; Picchio GR; Pastore C; Chaloin O; Hartley O; Offord R; Mosier DE
J Virol; 2001 Jan; 75(2):661-71. PubMed ID: 11134280
[TBL] [Abstract][Full Text] [Related]
17. Increasing CCL5/CCR5 on CD4+ T cells in peripheral blood of oral lichen planus.
Hu JY; Zhang J; Cui JL; Liang XY; Lu R; Du GF; Xu XY; Zhou G
Cytokine; 2013 Apr; 62(1):141-5. PubMed ID: 23490419
[TBL] [Abstract][Full Text] [Related]
18. Gene silencing of HIV chemokine receptors using ribozymes and single-stranded antisense RNA.
Qureshi A; Zheng R; Parlett T; Shi X; Balaraman P; Cheloufi S; Murphy B; Guntermann C; Eagles P
Biochem J; 2006 Mar; 394(Pt 2):511-8. PubMed ID: 16293105
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
[TBL] [Abstract][Full Text] [Related]
20. Analysis of second messenger pathways stimulated by different chemokines acting at the chemokine receptor CCR5.
Leach K; Charlton SJ; Strange PG
Biochem Pharmacol; 2007 Sep; 74(6):881-90. PubMed ID: 17645873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
